Mumbai, 31st July 2025 — Syncom Formulations (India) Limited, a long-standing leader in ethical pharmaceutical manufacturing, was awarded the ‘Outstanding Company in Global & Domestic Markets’ at the "Influx Connect" Business Excellence Awards 2025, held at the Jio Convention Center in Mumbai on 12th July 2025.

The event, presented by The Bharat Biz, recognized organizations that demonstrate scale, innovation, and impact across both Indian and international healthcare landscapes.

Syncom Formulations (India) Limited has built a solid reputation through its flagship Cratus brand — known for its scientifically-driven and ethically marketed pharmaceutical products. The company’s presence spans pan-India and numerous global markets, reflecting its strategic expansion and sustained product excellence.

With decades of commitment to quality, integrity, and access to healthcare, Syncom Formulations (India) Limited continues to set benchmarks in both regulated and emerging markets. Its dual-market presence exemplifies what it means to serve with purpose and scale.

The award was presented by Mr. Nilesh Gandhi, former Assistant Commissioner (Drugs), FDA Maharashtra — a key contributor to India’s pharmaceutical regulatory reforms and co-author of the Drugs & Cosmetics Act commentary.

This recognition affirms Syncom Formulations (India) Limited’s legacy of advancing healthcare with responsibility, scientific rigor, and global vision.